Rawisak Chanwat

268/1 Rama VI Road
Ratchathewi, 10400, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Sheep Liver as a Model for Advanced Laparoscopic Hepatic Resection Training.

Sheep Liver as a Model for Advanced Laparoscopic Hepatic Resection Training.

Journal: Asian journal of endoscopic surgery

Published: June 29, 2025

Asia-Pacific modified Delphi consensus conference on large hepatocellular carcinoma.

Asia-Pacific modified Delphi consensus conference on large hepatocellular carcinoma.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association

Published: October 28, 2024

Real-World Data on the Diagnosis, Treatment, and Management of Hepatocellular Carcinoma in the Asia-Pacific: The INSIGHT Study.

Real-World Data on the Diagnosis, Treatment, and Management of Hepatocellular Carcinoma in the Asia-Pacific: The INSIGHT Study.

Journal: Liver cancer

Published: April 11, 2023

Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma.

Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma.

Journal: Frontiers in oncology

Published: December 15, 2022

A genomic enhancer signature associates with hepatocellular carcinoma prognosis.

A genomic enhancer signature associates with hepatocellular carcinoma prognosis.

Journal: JHEP reports : innovation in hepatology

Published: September 06, 2022

Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma.

Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma.

Journal: Frontiers in oncology

Published: August 17, 2022

Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular Carcinoma.

Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular Carcinoma.

Journal: BMC cancer

Published: June 10, 2022

The Acquired Vulnerability Caused by CDK4/6 Inhibition Promotes Drug Synergism Between Oxaliplatin and Palbociclib in Cholangiocarcinoma.

The Acquired Vulnerability Caused by CDK4/6 Inhibition Promotes Drug Synergism Between Oxaliplatin and Palbociclib in Cholangiocarcinoma.

Journal: Frontiers in oncology

Published: February 16, 2022

The Tokyo 2020 terminology of liver anatomy and resections: Updates of the Brisbane 2000 system.

The Tokyo 2020 terminology of liver anatomy and resections: Updates of the Brisbane 2000 system.

Journal: Journal of hepato-biliary-pancreatic sciences

Published: September 01, 2021

Minimally invasive anatomic liver resection: Results of a survey of world experts.

Minimally invasive anatomic liver resection: Results of a survey of world experts.

Journal: Journal of hepato-biliary-pancreatic sciences

Published: August 31, 2021

Expert Consensus Guidelines: How to safely perform minimally invasive anatomic liver resection.

Expert Consensus Guidelines: How to safely perform minimally invasive anatomic liver resection.

Journal: Journal of hepato-biliary-pancreatic sciences

Published: August 30, 2021

Impact of COVID-19 on Hepatocellular Carcinoma Management: A Multicountry and Region Study.

Impact of COVID-19 on Hepatocellular Carcinoma Management: A Multicountry and Region Study.

Journal: Journal of hepatocellular carcinoma

Published: July 13, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026